VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience

About this update from Vyne Therapeutics Inc.

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) --  VYNE Therapeutics Inc. (Nasdaq: VYNE) ("VYNE" or the "Company") today announced that its previously announced special cash dividend (the "Cash Dividend"), declared in connection with the terms and conditions of the Agreement and Plan of Merger and Reorganization, entered into on December 17, 2025, as amended (the "Merger Agreement"), with Yarrow Bioscience, Inc. ("Yarrow") and Yellow Merger Sub Corp., was distributed, in cash, on July 23, 2026 to VYNE's stockholders of record as of July 22, 2026 (the "Record Date"), subject to the Nasdaq due bill procedures described below, based on their holdings as of the Record Date and during the Due Bill Period (as defined below) and prior to the reverse stock split. As previously disclosed, VYNE's reverse stock split at a ratio of 1-for-50 is expected to occur on July 24, 2026. Following the reverse stock split, VYNE's common stock is expected to begin trading on a post-reverse stock split basis on The Nasdaq Capital Market ("Nasdaq") on July 27, 2026 under CUSIP Number 92941V407 and ISIN Number US92941V4077. In addition, VYNE announced that the closing of the proposed merger (the "Merger") with Yarrow under the Merger Agreement is subject to the final review and approval of the combined company's Nasdaq listing application and is expected to occur early in the week of July 27, 2026, subject to Nasdaq approval. VYNE previously announced that the closing of the Merger was expected to occur on or about July 24, 2026, subject to the satisfaction or waiver of all conditions under the Merger Agreement, including Nasdaq approval. Following the closing of the Merger, the combined company's common stock is expected to begin trading on Nasdaq under the new name "Yarrow Bioscience, Inc.", ticker symbol "YARW". Because the Cash Dividend per share exceeds 25% of VYNE's stock price on the declaration date, it is subject to an ex-dividend date of one business day after the Cash Dividend is distributed to the Company's stockholders and warrant holders as of the Record Date, which occurred on July 23, 2026 (the "Payment Date"). Accordingly, Nasdaq set July 24, 2026 as the ex-dividend date for the Cash Dividend. In addition, VYNE understands that trades of VYNE's common stock entered into during the due bill period, which began July 21, 2026 (the business day before the Record Date) ...

View stock analysis, news, and events for Vyne Therapeutics Inc.